What is SynChem?
Founded in 1997 and headquartered in Elk Grove Village, Illinois, SynChem has established itself as a critical partner for pharmaceutical, biotech, and material science enterprises. The company specializes in high-precision organic synthesis, medicinal chemistry, and process development, operating under stringent cGMP conditions. By providing essential building blocks and unnatural amino acids, SynChem serves as a foundational pillar for researchers navigating the complexities of modern drug discovery. Their commitment to advanced analytical chemistry and separation methods has solidified their reputation as a high-quality service provider in a competitive global landscape.
How much funding has SynChem raised?
SynChem has raised a total of $48K across 1 funding round:
Debt
$48K
Debt (2021): $48K with participation from PPP
Key Investors in SynChem
PPP
Public-Private Partnership
What's next for SynChem?
The infusion of substantial expansion capital marks a pivotal transition for SynChem as it scales its infrastructure to meet the growing demand for outsourced R&D services. Moving forward, the company is expected to leverage this investment to enhance its cGMP manufacturing capacity and broaden its portfolio of proprietary chemical building blocks. By deepening its technical expertise in medicinal chemistry, SynChem aims to shorten the development timelines for its partners, effectively positioning itself as an indispensable asset in the pharmaceutical supply chain. This strategic growth phase will likely focus on operational efficiency and the integration of next-generation analytical technologies to maintain its competitive edge in the contract research market.
See full SynChem company page
